BioSpace News Archive

FDA

FDA Action Alert: Merck, Jazz, Regeneron, Sanofi and TherapeuticsMD

This week will have moderate activity by the U.S. Food and Drug Administration (FDA). Although they jumped the gun on Regeneron and Sanofi’s cancer drug, there are still plenty of other decisions being made this week. Here’s a look.

October 19, 2018
·
3 min read
·
Mark Terry
Biotech Bay

J&J’s JLABS Incubators Show off Success of First Six Years

It has been six years since Johnson & Johnson first launched its JLABS incubators for the life science industry with a vision of providing assistance to startups that could potentially bring about a new paradigm of care for patients.

October 19, 2018
·
2 min read
·
Alex Keown